A novel S269C mutation in fibroblast growth factor receptor 3 in a Japanese child with hypochondroplasia

1Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Functionally activating mutations in fibroblast growth factor receptor 3 (FGFR3) can cause four types of autosomal dominant skeletal dysplasia with short-limbed dwarfism that include the mildest phenotype, hypochondroplasia (HCH). A novel mutation (c.805A>T, p.S269C) was identified in a Japanese infant with HCH through direct sequencing of all FGFR3 exons and exon/intron boundaries. This mutation creates an additional cysteine residue in the extracellular region of FGFR3 that results in the functional activation of FGFR3.

Cite

CITATION STYLE

APA

Takahashi, I., Kondo, D., Oyama, C., Yano, T., Tamura, H., Noguchi, A., & Takahashi, T. (2018). A novel S269C mutation in fibroblast growth factor receptor 3 in a Japanese child with hypochondroplasia. Human Genome Variation, 5(1). https://doi.org/10.1038/s41439-018-0001-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free